Compare IOVA & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | STBA |
|---|---|---|
| Founded | 2007 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2008 | 1995 |
| Metric | IOVA | STBA |
|---|---|---|
| Price | $4.08 | $47.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | $9.00 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 12.1M | 196.8K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.29% |
| EPS Growth | ★ 14.84 | 2.35 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | N/A |
| Revenue This Year | $47.74 | $10.20 |
| Revenue Next Year | $40.31 | $4.14 |
| P/E Ratio | ★ N/A | $50.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.67 | $34.01 |
| 52 Week High | $5.63 | $47.50 |
| Indicator | IOVA | STBA |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 69.61 |
| Support Level | $2.07 | $42.52 |
| Resistance Level | $4.35 | N/A |
| Average True Range (ATR) | 0.36 | 0.96 |
| MACD | -0.02 | 0.26 |
| Stochastic Oscillator | 40.45 | 98.58 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.